News
There is widespread hope for curbing HIV after the United States Food and Drug Administration (FDA) approved an injectable ...
A secondary analysis of a large trial shows that exposure to the HIV drug abacavir is linked to an elevated risk for major ...
Learn about HIV medications and antiretroviral therapy (ART). Understand the different types, brand names, and how these treatments help manage HIV and maintain your health.
4d
The Brighterside of News on MSNGame-changing molecule turns HIV against itself to halt activityIn the ongoing fight against HIV, scientists have taken a new step toward long-term control of the virus. Researchers have ...
HIV remains incurable but manageable. Johns Hopkins found a way to silence it long-term using a molecule from the virus itself, offering hope for future gene therapy without daily meds.
National HIV and sub national HIV Estimates and Projections show that the Greater Accra, Ashanti and Eastern regions have the ...
If approved, doravirine/islatravir would be the first two-drug HIV treatment regimen without an integrase inhibitor, ...
When it comes to a clinical study to evaluate the therapeutic effect of Shivagutika treatment in patients with HIV, it was ...
South Africa might be cushioned from the global fallout in reduced funding for HIV prevention and treatment, but it has not been spared the effects, a global health report has found.
The risk for MACEs was higher among patients with HIV infection receiving abacavir- vs tenofovir-based ART regimens.
Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration ...
Incomplete immune recovery despite sustained virologic suppression in patients with HIV was associated with increased risk for incident cancer.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results